Health Care Delivery

June 24th 2025

Osteoarthritis leads the burden, projected to affect 50% of postmenopausal women by 2045.

June 24th 2025

Belimumab is now the first and only subcutaneous biologic therapy approved for at-home administration in pediatric lupus nephritis.

June 23rd 2025

Up to 257 million Americans could benefit from these prior authorization reforms that could have cross-market implications on health care plans administered through commercial insurers, Medicare Advantage, and Medicaid.

June 20th 2025

It's a critical time to spotlight the dire health disparities affecting Black Americans, from premature deaths to maternal care, and the urgent need for systemic reforms.